Latest Shareholder Vote News

Amaero Ltd secured strong shareholder approval for its US re-domiciliation schemes and a director option grant at virtual meetings held on 5 June 2026.

Matrix Composites & Engineering has lodged its Scheme Booklet with ASIC, setting the stage for a July shareholder vote on its proposed acquisition by Advanced Innergy Holdings. The deal, backed by an Independent Expert and the Matrix board, awaits court approval and shareholder endorsement.

Sabre Resources has received Northern Territory government approval to drill up to 5,000 metres at Kurundi North, targeting high-potential copper-gold systems analogous to Tennant Creek. The program awaits shareholder approval of a major acquisition and aims to unlock value in a resurging mineral province.

Arafura Rare Earths has officially opened its share purchase plan following ASIC lodgement, while also dispatching notices for a July extraordinary general meeting in Perth.

Matrix Composites & Engineering has secured Federal Court approval to hold a shareholder meeting on 6 July 2026 to vote on Advanced Innergy's full acquisition scheme. The court also approved the release of a Scheme Booklet, which includes an Independent Expert's report endorsing the deal as fair and reasonable.

Magnetic Resources NL shareholders overwhelmingly approved Genesis Minerals’ $639 million acquisition scheme, paving the way for final court approval next week.

Qoria Limited has dispatched its Scheme Booklet to shareholders detailing the proposed acquisition by Aura Consolidated Group. While the independent expert finds the deal not fair but reasonable, Qoria’s board unanimously recommends approval, pending no superior proposal.

The Takeovers Panel has declined to investigate Skin Elements Limited's allegations of undisclosed investor associations following a $2.5 million placement, after 62 Capital agreed to waive transfer restrictions on placement securities.

Desert Metals Limited has raised $1 million through a placement at a 2.9% premium, backing exploration at its Scotty Lithium and Monger Gold projects alongside new growth opportunities.

Green Cross Health plans to sell its Medical division, The Doctors, for NZ$270 million to Tend Health, refocusing on its pharmacy business. Completion hinges on shareholder approval expected by July 2026.

Paradigm Biopharmaceuticals has successfully raised $21.375 million through an oversubscribed Share Purchase Plan and a recent placement, bolstering its balance sheet ahead of key Phase 3 trial milestones.

Nova Minerals shareholders and Nasdaq warrantholders overwhelmingly approved schemes to restructure the company under a new US holding entity, pending final court approval.